SESSION 5

MYELOFIBROSIS (MF)

H. Gisslinger, T. Barbui

9:30 - 9:55

Allogeneic stem cell transplantation

N. Gagelmann

9:55 - 10:25

To treat or not to treat “early MF” (prePMF and low risk MF)

pro: V. Buxhofer-Ausch, con: F. Passamonti

10:25 - 10:35

Discussion

10:35 - 11:00

Overt MF – Progress beyond JAK2 monotherapy

F. Heidel

11:00 - 11:25

Ongoing clinical research

C. Harrison

11:25 - 11:35

Concluding words

H. Gisslinger